| Literature DB >> 35771247 |
Francesco Giganti1,2, Alexander P Cole3, Fiona M Fennessy4, Timothy Clinton3, Pedro Lopes Da Frota Moreira4, Mariana Costa Bernardes4, Carl-Fredrik Westin4, Deepa Krishnaswamy4, Andriy Fedorov4, Daniel A Wollin3, Bjoern Langbein3, Nicola Frego3, Muhieddine Labban3, Joy S Badaoui3, Steven L Chang3, Logan G Briggs3, Junichi Tokuda4, Alessandro Ambrosi5, Alex Kirkham6, Mark Emberton7,8, Veeru Kasivisvanathan7,8, Caroline M Moore7,8, Clare Allen6, Clare M Tempany4.
Abstract
OBJECTIVES: The Prostate Imaging Quality (PI-QUAL) score is a new metric to evaluate the diagnostic quality of multiparametric magnetic resonance imaging (MRI) of the prostate. This study assesses the impact of an intervention, namely a prostate MRI quality training lecture, on the participant's ability to apply PI-QUAL.Entities:
Keywords: Biopsy; Magnetic resonance imaging; Prostatic neoplasms; Urogenital neoplasms
Year: 2022 PMID: 35771247 PMCID: PMC9244244 DOI: 10.1007/s00330-022-08947-5
Source DB: PubMed Journal: Eur Radiol ISSN: 0938-7994 Impact factor: 7.034
Assessment of the diagnostic quality of multiparametric MRI scans using the PI-QUAL score
| PI-QUAL score | Criteria | Clinical implications |
|---|---|---|
| 1 | All mpMRI sequences are below the minimum standard for diagnostic quality | It is NOT possible to rule in all significant lesions * It is NOT possible to rule out all significant lesions * |
| 2 | Only one mpMRI sequence is of acceptable diagnostic quality | |
| 3 | At least two mpMRI sequences taken together are of acceptable diagnostic quality | It is possible to rule in all significant lesions It is NOT possible to rule out all significant lesions |
| 4 | Two or more mpMRI sequences are independently of optimal diagnostic quality | It is possible to rule in all significant lesions It is possible to rule out all significant lesions |
| 5 | All mpMRI sequences are of optimal diagnostic quality |
*Therefore, reports should not include PI-RADS or Likert scores
Legend. PI-QUAL Prostate Imaging QUALity; mpMRI multiparametric magnetic resonance imaging; PI-RADS Prostate Imaging Reporting and Data System
Fig. 1Harvard Medical School (A, B) and main entrance of Brigham and Women’s Hospital (C, D) in Boston, Massachusetts, USA. The images were taken during the teaching fellowship in January 2022
Fig. 2Chronologic framework of the teaching fellowship
Fig. 3Scoring sheet for pre-teaching scans
Fig. 4PI-QUAL scoring sheet for post-teaching scans. Reprinted with permission from Elsevier from Giganti F, Allen C, Emberton M, Moore CM, Kasivisvanathan V, for the PRECISION study group. Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial. Eur Urol Oncol (2020); 3(5):615-619.
List of participants with their background and their level of experience in prostate MRI interpretation
| Participant | Background | Experience in prostate MRI (years) | Number of prostate MR scans seen per year |
|---|---|---|---|
| 1 | Radiologist, MD | 30 | 1,500 |
| 2 | 20 | 1,000 | |
| 3 | Computer scientist, PhD | 5 | 100 |
| 4 | 0 | < 10 | |
| 5 | 1 | 100 | |
| 6 | 5 | 200 | |
| 7 | 0 | < 10 | |
| 8 | Urologist, MD | 9 | 200 |
| 9 | 5 | 300 | |
| 10 | 2 | 100 | |
| 11 | 0 | < 10 | |
| 12 | 0 | < 10 | |
| 13 | 15 | 100 | |
| 14 | 0 | < 10 | |
| 15 | 8 | 100 | |
| 16 | Physicist, PhD | 1 | 100 |
Legend. MD medical doctor; PhD doctor of philosophy; MRI magnetic resonance imaging; MR magnetic resonance
List of MR vendors and systems, magnets, and PI-QUAL scores (according to the reference standard) for each scan in the pre- and post-teaching cohorts
| MR vendor and system | Magnet (T) | PI-QUAL score | |
|---|---|---|---|
| Pre-teaching | |||
| Scan 1 | Siemens Skyra | 3 | 4 |
| Scan 2 | Siemens Verio | 3 | 3 |
| Scan 3 | Siemens Avanto | 1.5 | 4 |
| Scan 4 | Philips Intera | 1.5 | 2 |
| Scan 5 | Philips Ingenia | 1.5 | 4 |
| Scan 6 | GE Signa | 1.5 | 2 |
| Scan 7 | Siemens Skyra | 3 | 2 |
| Scan 8 | Siemens Skyra | 3 | 2 |
| Scan 9 | Siemens Verio | 3 | 4 |
| Scan 10 | Siemens Prisma | 3 | 5 |
| Post-teaching | |||
| Scan 1 | GE Optima | 1.5 | 4 |
| Scan 2 | Philips Ingenia | 3 | 4 |
| Scan 3 | Philips Ingenia | 3 | 4 |
| Scan 4 | GE Signa | 1.5 | 4 |
| Scan 5 | GE Optima | 1.5 | 1 |
| Scan 6 | Philips Ingenia | 1.5 | 4 |
| Scan 7 | Siemens Sola | 1.5 | 5 |
| Scan 8 | GE Optima | 1.5 | 2 |
| Scan 9 | GE Optima | 1.5 | 1 |
| Scan 10 | Philips Ingenia | 3 | 5 |
Legend. MR magnetic resonance; T Tesla; PI-QUAL Prostate Image Quality
Fig. 5Average area under the curve (AUC) for the evaluation of image quality (suboptimal vs optimal) in the pre-teaching (blue, dash-dotted line) and post-teaching (red, dashed line) cohorts, with shaded areas and square brackets representing the 95% confidence intervals (A). AUCs for the evaluation of image quality stratified by experience (i.e., < or > than 100 prostate MR scans evaluated) before (B) and after (C) teaching
PI-QUAL scores given by each participant for each scan after teaching, and reference standard
| Scan 1 | Scan 2 | Scan 3 | Scan 4 | Scan 5 | Scan 6 | Scan 7 | Scan 8 | Scan 9 | Scan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PI-QUAL reader 1 | 3 | |||||||||
| PI-QUAL reader 2 | 5 | 2 | 1 | 4 | ||||||
| PI-QUAL reader 3 | 1 | 4 | ||||||||
| PI-QUAL reader 4 | 5 | 1 | 2 | 4 | 1 | 4 | ||||
| PI-QUAL reader 5 | 3 | 3 | 3 | 1 | 2 | 4 | ||||
| PI-QUAL reader 6 | 2 | 2 | 4 | 2 | 4 | |||||
| PI-QUAL reader 7 | 5 | 1 | 2 | 4 | ||||||
| PI-QUAL reader 8 | 3 | 3 | ||||||||
| PI-QUAL reader 9 | 3 | 3 | 2 | 1 | 3 | |||||
| PI-QUAL reader 10 | 1 | 3 | 2 | 5 | 1 | 2 | ||||
| PI-QUAL reader 11 | 5 | 2 | 1 | 4 | ||||||
| PI-QUAL reader 12 | 1 | 4 | ||||||||
| PI-QUAL reader 13 | 2 | 4 | 3 | 2 | 4 | |||||
| PI-QUAL reader 14 | 4 | 2 | ||||||||
| PI-QUAL reader 15 | 3 | 3 | 4 | 1 | 3 | |||||
| PI-QUAL reader 16 | 1 | 1 | 2 | 4 | ||||||
Legend. PI-QUAL Prostate Imaging Quality. In boldface are cases concordant with the reference standard
Fig. 6Two cases of prostate MRI from the two cohorts (pre- and post-teaching). The first case [A axial T2-weighted imaging; B diffusion-weighted imaging (high b value: 1,000 s/mm2); C apparent diffusion coefficient map; D dynamic-contrast enhanced sequences] is from the pre-teaching cohort and the reference standard was PI-QUAL 2, as only T2-WI is of sufficient diagnostic quality. Only 7/16 participants gave the correct PI-QUAL score for this scan, with 1/16 giving a PI-QUAL score of 3, 3/16 a PI-QUAL score of 4 and 5/16 a PI-QUAL score of 5. The second case [E axial T2-weighted imaging; F diffusion-weighted imaging (high b value: 2,000 s/mm2); G apparent diffusion coefficient map; H dynamic-contrast enhanced sequences] is from the post-teaching cohort and the reference standard was PI-QUAL 5. All patients scored this scan as of optimal diagnostic quality (i.e., PI-QUAL score 4 or 5; in detail: 9/16 scored PI-QUAL 4 and 7/16 scored PI-QUAL 5)